Fatty acid synthase: Specific target for cancer therapy

Acta Biochimica et Biophysica Sinica

Volumn 35, Issue 1, 2003, Pages 1-5

  Li, Xiang Hong ^a   Hou, Yong Tai ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cancer; Fatty acid synthase; Inhibitor

Indexed keywords

ENZYME; FAS ANTIGEN; FATTY ACID; FATTY ACID SYNTHASE;

CANCER GROWTH; CANCER THERAPY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENERGY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; HUMAN; LABELING INDEX; LIPID COMPOSITION; PROTEIN EXPRESSION; SHORT SURVEY; TISSUE;

ANIMALS; CATECHIN; CERULENIN; FATTY ACID SYNTHETASE COMPLEX; HUMANS; NEOPLASMS; TRICLOSAN;

EID: 0037223326     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (45)

1. Smith S. The animal fatty acid synthase: One gene, one polypeptide, seven enzymes. FASEB J, 1994, 8: 1248-1259
2. Weiss L, Hoffmann GE, Schreiber R, Andres H, Fuchs E, Korber E, kolb HJ. Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler, 1986, 367: 905-912
3. Paulauskis JD, Sul HS. Cloning and expression of mouse fatty acid synthase and other specific mRNAs. Developmental and hormonal regulation in 3T3-L1 cells. J Biol Chem, 1988, 263: 7049-7054
4. Moustaid N, Sul HS. Regulation of expression of the fatty acid synthase gene in 3T3-L1 cells by differentiation and triiodothyronine. J Biol Chem, 1991, 266: 18550-18554
5. Paulauskis JD, Sul HS. Hormonal regulation of mouse fatty acid synthase gene transcription in liver. J Biol Chem, 1989, 264: 574-577
6. Volpe JJ, Marasa JC. Hormonal regulation and fatty acid synthase, acetyl-CoA carboxylase and fatty acid synthesis in mammalian adipose tissue and liver. Biochim Biophys Acta, 1975, 380: 454-472
7. Blake WL, Clarke SD. Suppression of rat hepatic fatty acid synthase and S14 gene transcription by dietary polyunsaturated fat. J Nutr, 1990, 120: 1727-1729
8. Jump DB, Clarke SD, Thelen A, Liimatta M. Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res, 1994, 35: 1076-1084
9. Teruel T, Valverde AM, Benito M, Lorenzo M. Transforming growth factor beta 1 induces differentiation-specific gene expression in fetal rat brown adipocytes. FEBS Lett, 1995, 364: 193-197
10. Jones BH, Kim JH, Zemel MB, Woychik RP, Michaud EJ, Wilkison WO, Moustaid N. Upregulation of adipocyte metabolism by agouti protein: Possible paracrine actions in yellow mouse obesity. Am J Physiol, 1996, 270: E192-196
11. Lu Z, Gu Y, Rooney SA. Transcriptional regulation of the lung fatty acid synthase gene by glucocorticoid, thyroid hormone and transforming growth factor-beta 1. Biochim Biophys Acta, 2001, 1532: 213-222
12. Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res, 1953; 13: 27-29
13. Warburg O, Posener KEN. Uber den stoffwechsel der carcinomzelle. Biochemistry, Z 1924, 152: 309-335
14. Nakashima RA, Paggi MG, Pedersen PL. Contributions of glycolysis and oxidative phosphorylation to adenosine 5′-triphosphate production in AS-30D hepatoma cells. Cancer Res, 1984, 44: 5702-5706
15. Nakashima RA, Paggi MG, Scott LJ, Pedersen PL. Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line. Cancer Res, 1988, 48: 913-919
16. Ookhtens M, Kannan R, Lyon I, Baker N. Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol, 1984, 247: R146-153
17. Kuhajda FP, Katumuluwa AL, Pasternack GR. Expression of haptoglobin-related protein and its potential role as a tumor antigen, Proc Natl Acad Sci USA, 1989, 86: 1188-1192
18. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR. Fatty acid synthesis: A potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA, 1994, 91: 6379-6383
19. Alo PL, Visca P, Trombetta G, Mangoni A, Lenti L, Monaco S, Botti C et al. Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori, 1999, 85: 35-40
20. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol, 1996, 27: 917-921
21. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF Jr et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res, 2001, 61: 5974-5978
22. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, Kuhajda FP et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol, 1997, 150: 201-208
23. Pizer ES, Lax SF, Kuhajda FP, Pasternack GR, Kurman RJ. Fatty acid synthase expression in endometrial carcinoma: Correlation with cell proliferation and hormone receptors. Cancer, 1998, 83: 528-537
24. Gansler TS, Hardman W III, Hunt DA, Schaffel S, Hennigar RA. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol, 1997, 28: 686-692
25. Kusakabe T, Nashimoto A, Honma K, Suzuki T. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology, 2002, 40: 71-79
26. Kuhajda FP, Pasternack GR. Cancer Related Antigen. U. S. Patent No. 5, 864, 011, 1999
27. Oskouian B. Overexpression of fatty acid synthase in SKBR3 breast cancer cell line is mediated via a transcriptional mechanism. Cancer Lett, 2000, 149: 43-51
28. Li JN, Mahmoud MA, Han WF, Ripple M, Pizer ES. Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp Cell Res, 2000, 261: 159-165
29. Van de Sande T, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res, 2002, 62: 642-646
30. Christie WW, Hunter ML, Clegg RA. The effects of cerulenin on lipid metabolism in vitro in cellular preparations from the rat. Biochim Biophys Acta, 1981, 666: 284-290
31. Omura S. The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacterial Rev, 1976, 40: 681-697
32. Moche M, Schneider G, Edwards P, Dehesh K, Lindqvist Y. Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase. J Biol Chem, 1999, 274: 6031-6034
33. Pizer ES, Wood FD, Heine HS, Romantsev FE, Pasternack GR, Kuhajda FP. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res, 1996, 56: 1189-1193
34. Pizer ES, Chrest FJ, DiGiuseppe JA, Han WF. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res, 1998, 58: 4611-4615
35. Pizer ES, Wood FD, Pasternack GR, Kuhajda FP. Fatty acid synthase (FAS): A target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res, 1996, 56: 745-751
36. Furuya Y, Akimoto S, Yasada K, Ito H. Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis. Anticancer Res, 1997, 17: 4589-4593
37. Funabashi H, Kawaguchi A, Tomoda H, Omura S, Okuda S, Iwasaki S. Binding site of cerulenin in fatty acid synthetase. J Biochem, 1989, 105: 751-755
38. Pizer ES, Jackisch C, Wood FD, Pasternack GR, Davidson NE, Kuhajda FP. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res, 1996, 56: 2745-2747
39. Thupari JN, Pinn ML, Kuhajda FP. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem Biophys Res Commun, 2001, 285: 217-223
40. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science, 2000, 288: 2379-2381
41. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA, 2000, 97: 3450-3454
42. Liu B, Wang Y, Fillgrove KL, Anderson VE. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBR-3 breast cancer cells. Cancer Chemother Pharmacol, 2002, 49: 187-193
43. 2+-ATPase mRNA expression in NIH 3T3 cells. Biochem Biophys Res Commun, 1993, 197: 1483-1491
44. Pizer ES, Kurman RJ, Pasternack GR, Kuhajda FP. Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium. Int J Gynecol Pathol, 1997, 16: 45-51
45. Wang X, Tian W. Green tea epigallocatechin gallate: A natural inhibitor of fatty-acid synthase. Biochem Biophy Res Commun, 2001, 288: 1200-1206